CD40-activated B Cells From Patients With Systemic Lupus Erythematosus Can Be Modulated by Therapeutic Immunoglobulins in Vitro

Archivum Immunologiae et Therapiae Experimentalis - Switzerland
doi 10.1007/s00005-009-0048-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Anti-B Cell Therapy in Patients With Systemic Lupus Erythematosus

Modern Rheumatology Journal
2017English

Dendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic Tools

Mediators of Inflammation
ImmunologyCell Biology
2016English

Correction of Interleukin-2 Production in Patients With Systemic Lupus Erythematosus by Removal of Spontaneously Activated Suppressor Cells.

Journal of Clinical Investigation
Medicine
1985English

Tuberculosis in Patients With Systemic Lupus Erythematosus.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1982English

Bone Health in Patients With Systemic Lupus Erythematosus

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2019English

Therapeutic Inhibition of Proteasomes in Systemic Lupus Erythematosus

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

Retinal Disease in Patients With Systemic Lupus Erythematosus

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2000English

Liver Dysfunction in Patients With Systemic Lupus Erythematosus

Internal Medicine
Internal MedicineMedicine
2013English

Ischemic Attacks in Patients With Systemic Lupus Erythematosus.

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
1984English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy